In many ways, the patient in front of me — a new-to-me patient with recurrent lung cancer — was exactly the kind of consultation I had spent nearly two decades training to manage.
We sat together and reviewed the scans. We discussed the biopsy confirming recurrent adenocarcinoma. I explained what the imaging showed, what we knew with confidence, and, just as importantly, what we still did not know.
There were pieces of the staging that remained incomplete. A brain MRI had yet to be performed. A pleural effusion still needed to be sampled. Based on the imaging, I explained that there was a real possibility the disease had become metastatic, but until staging was complete, we could not honestly define treatment intent.
If the additional studies demonstrated locally advanced disease, our goal would remain cure. Conversely, if they demonstrated metastatic disease, our goal would shift toward long-term disease control.
These conversations are among the hardest in oncology. They are also among the most routine. Patients cry. Families ask impossible questions. Hope and uncertainty somehow find a way to occupy the same room. That morning felt no different until I walked out of the exam room.
Within minutes, someone stopped me in the hallway. “Is it really Stage IV?”
Then another. “So you don’t think this is curable?”
A third asked whether I was certain additional staging was necessary.
By lunchtime, I realized my consultation had become the topic of conversation throughout the clinic. The reaction wasn’t hostile or argumentative. People were simply worried. At first, I couldn’t understand why. From my perspective, nothing extraordinary had happened. A patient with recurrent lung cancer required complete staging before treatment intent could be established. We would move quickly, but we would not skip the step that determined cure or palliation.
Then someone filled in the missing piece. For me, the patient was simply another consultation, someone I had met 45 minutes earlier. For everyone else, he had been part of the practice for decades. The physicians knew him personally. The nurses knew him. The front desk knew him. He wasn’t just a patient. He was part of the clinic’s story. Suddenly, the conversations in the hallway made sense. No one was really asking me about PET scans or pleural cytology. They were asking about someone they cared about.
Until that moment, I had assumed I was navigating another complex lung cancer consultation. I hadn’t considered that everyone else in the building had been carrying years — sometimes decades — of relationships into the room with them. It made me wonder whether I had just witnessed something we almost never discuss in medicine.
Serious illness changes everyone around a patient. Physicians, nurses, office staff, and family members all feel the instinct to move quickly, to intervene, to do something. The deeper the relationship, the stronger that instinct can become.
Evidence-based medicine often asks us to do the opposite. It asks us to pause, to tolerate uncertainty, to complete staging before defining treatment, and to let biology and not emotion determine the next step. That can be surprisingly difficult when everyone in the room — not just family — desperately wants the answer to be different.
We devote considerable attention to financial conflicts of interest because they have the potential to shape judgment. We disclose consulting relationships, stock ownership, research funding, and industry ties.
I am not sure if emotional conflicts deserve the same attention. Not because they arise from self-interest, but precisely because they arise from compassion. They are the quieter conflicts: the patient everyone knows, the family every nurse has cared for, the physician who has followed someone for 20 years.
None of these relationships are unethical. In fact, they are among the greatest strengths of community medicine. But meaningful relationships deserve the same humility we bring to every other potential source of bias.
Familiarity can alter urgency. Affection can narrow our tolerance for uncertainty. Shared history can make action feel more comfortable than waiting, even when waiting is what the evidence requires.
My medical recommendation never changed. What changed was my understanding of objectivity. I had always thought bias was something physicians carried within themselves: a financial incentive, a preconceived opinion, an attachment to a particular treatment.
I left the clinic contemplating if bias can also exist in relationships built over decades, in communities small enough that physicians become neighbors, and in the patients we come to know so well that their diagnosis begins to feel personal.
Those emotions are not evidence of poor medicine. They are evidence that we care. But caring does not eliminate bias. Perhaps the greatest threat to objectivity in medicine is not that we care too little. It is that, sometimes, we care so much that we stop noticing how deeply it shapes our judgment.
When have your feelings for a patient made waiting harder? Share in the comments.
